Description

Mandrax Quaalude

Mandrax (Quaalude) Methaqualone, formerly sold under the brand name Quaalude and Mandrax, is a sedative and hypnotic medication. It is a member of the quinazolinone class. The sedative–hypnotic activity of methaqualone was first noted in the 1950s. In 1962, Mandrax (Methaqualone) 300mg methaqualone was patented in the US by Wallace and Tiernan. Quaaludes (methaqualone) is a synthetic, barbiturate-like, central nervous system depressant and a popular recreational drug in the U.S. from the 1960s until the 1980s, when its use was made illegal by the Drug Enforcement Agency (DEA). The active ingredient, methaqualone, is an anxiolytic (lowers anxiety) and a sedative-hypnotic drug that leads to a state of drowsiness.

 

These drugs, imprinted with the number “714” on the tablet, were initially introduced as a safe barbiturate substitute to help induce sleep but were later shown to have addiction and withdrawal symptoms similar to other prescription barbiturates. Quaaludes are rarely encountered on the streets in the U.S. today but are occasionally confiscated coming across the border.

Quaaludes dosage

When it was a legal medication, methaqualone was available in tablet and capsule form and came in different strengths.

• Oral Quaaludes dosages ranged from 75 to 150 mg for light sedation. Captagon

• A commonly prescribed dose was 300 mg. Up to 600 mg was used for strong sedation.

• Tolerance develops rapidly and some users may take up to 2000 mg daily to achieve the same effects.

• The onset of action is approximately 30 minutes after taking Quaaludes and duration of action is between 5 to 8 hours.

 

Quaaludes Overall Benefits

Despite its potential for abuse and severe side effects, Mandrax 300 mg injection offers several significant benefits, particularly in controlled medical settings.

Benefits in Medical Settings

1. Rapid Onset of Action: The injection form provides rapid sedation and anxiolysis, making it suitable for emergency situations or acute care settings.
2. Effective Sedation: Highly effective in inducing sedation for procedures or in patients requiring immediate calming effects.
3. Muscle Relaxation: The muscle-relaxant properties are beneficial in certain medical conditions requiring muscle relaxation.

Benefits in Controlled Use

1. Management of Severe Insomnia: Mandrax can be effective in treating severe, refractory insomnia under strict medical supervision.
2. Anxiety Relief: Provides significant anxiolytic effects, which can be beneficial in acute anxiety episodes.

Mechanism of Action

Mandrax 300 mg tablets, or methaqualone, works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits brain activity.

This action results in a calming effect on the central nervous system, leading to sedation, muscle relaxation, and anxiolysis.

The rapid onset of action when administered via injection makes it particularly useful for immediate relief in acute care settings.

 

Comparisons with Other Sedative-Hypnotics

Mandrax vs. Diazepam (Valium)

1. Onset of Action: Mandrax has a rapid onset of action, similar to diazepam, but its effects are often more intense.
2. Duration: Diazepam has a longer half-life, providing more prolonged effects, whereas Mandrax’s effects are more short-lived but potent.
3. Side Effect Profile: Mandrax has a higher risk of severe side effects and dependence compared to diazepam.

Mandrax vs. Barbiturates

1. Safety Profile: Both Mandrax and barbiturates have high abuse potential and risk of overdose. However, Mandrax is generally considered to have a narrower therapeutic window.
2. Efficacy: Both are effective for sedation and anxiolysis, but the choice depends on the specific clinical scenario and patient history